# CASI Pharmaceuticals, Inc. — Form D

CASI Pharmaceuticals, Inc. of BEIJING, F4, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-15. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-07-15
- Form: D
- Accession: 0001104659-24-079852
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 7
- Date of first sale: 2024-06-26
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-518792

## Issuer

- Name: CASI Pharmaceuticals, Inc.
- CIK: 0001962738
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2023
- Address: 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT, BEIJING, F4, 100025
- Phone: 86 10 6561 8789

## Officers, directors & promoters (36)

_Showing 25 of 36 people._

| Name | Role | Location |
| --- | --- | --- |
| Thomas Folinsbee | Director | Beijing, F4 |
| Wei-Wu He | Director | Rockville, MD |
| Zhenbo Su | Director | Beijing, F4 |
| Alexander Y Wu | Director | Rockville, MD |
| Xuebo Y Zeng | Director | Beijing, F4 |
| Wei Y Gao | Executive Officer | Beijing, F4 |
| Wei-Wu He | Executive Officer | Rockville, MD |
| Hai Y Huang | Executive Officer | Beijing, F4 |
| Kun Y Qian | Executive Officer | Beijing, F4 |
| Chunhua Y Wang | Executive Officer | Beijing, F4 |
| Wei (Larry) Y Zhang | Executive Officer | Beijing, F4 |
| Alexander A Zukiwski | Executive Officer | Rockville, MD |
| Wei-Wu He | Related Person | Rockville, MD |
| James Huang | Related Person | South San Francisco, CA |
| Zhenbo Su | Related Person | Beijing, F4 |
| Thomas Folinsbee | Related Person | Beijing, F4 |
| Wei Gao | Related Person | Beijing, F4 |
| Wei Y. Gao | Executive Officer | Beijing, F4 |
| Alexander A. Zukiwski | Executive Officer | South San Francisco, CA |
| Hai Y. Huang | Executive Officer | Beijing, F4 |
| Wei (Larry) Y. Zhang | Executive Officer | South San Francisco, CA |
| Barbara A. Krebs-Pohl | Director | South San Francisco, CA |
| Chunhua Y. Wang | Executive Officer | Beijing, F4 |
| Kun Y. Qian | Executive Officer | Beijing, F4 |
| Xuebo Y. Zeng | Director | Beijing, F4 |

## Other filings by this issuer (4)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-04-28](https://search.stillhousedata.com/formd/0001962738-26-000004) | D | $5.0M | $5.0M |
| [2026-02-26](https://search.stillhousedata.com/formd/0001962738-26-000003) | D | $5.0M | $5.0M |
| [2026-01-28](https://search.stillhousedata.com/formd/0001962738-26-000002) | D | $5.0M | $5.0M |
| [2026-01-28](https://search.stillhousedata.com/formd/0001962738-26-000001) | D | $5.0M | $5.0M |

## More

- [CIK 1962738 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1962738&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-24-079852.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.